Blog - Page 3777 of 5383

TuesdaySep 15, 2009 10:09 am

BrainStorm Cell Therapeutics Inc. (BCLI.OB) Enters into a Strategic Agreement as it Approaches Clinical Trials for ALS

BrainStorm Cell Therapeutics Inc. has been gaining national recognition as a leading developer of adult stem cell technologies. Today, the company announced a major strategic agreement with Harlan Biotech Israel Ltd. (HBI) in order to complete pre-clinical safety experiments for the company’s innovative therapy for Amyotrophic Lateral Sclerosis (ALS), which is famously known as Lou Gehrig’s disease because it claimed the life of the famed baseball player. This agreement will add to another agreement entered with PPS which was announced on August 31, 2009. Together, these agreements will allow the young company to complete the experiments required to submit an…

TuesdaySep 15, 2009 10:04 am

Hyperdynamics Corp. (HDY) Signs Memorandum of Understanding with Guinea

Hyperdynamics Corp. is an independent oil and gas company with operations in the Republic of Guinea which is located in West Africa. The company has the sole exploration and production rights over Guinea's offshore region, which covers about 31,000 square miles. Today there are few regions in the world that offer the opportunity to find world-class oil and gas reserves. Some of the regions include the deep waters of the Gulf of Mexico and offshore Brazil. Another current hotbed of lucrative exploration activity is the waters offshore of western Africa. Hyperdynamics' license is the largest offshore exploration license in West…

TuesdaySep 15, 2009 9:39 am

Consorteum Holdings Inc. (CSRH.OB) to Capitalize on Emerging International Markets through Newly Formed JV

Consorteum Holdings Inc. announced today that it has formed a new Joint Venture partnership with Chicago-based Trans Screen Group of Illinois. According to the press release, Trans Screen will leverage Consorteum Holdings’ expertise to provide financial services solutions to a number of new emerging global markets. Quent Rickerby, President & COO of Consorteum Holdings Inc., stated, “This new joint venture further demonstrates the importance of the company’s global business model, while significantly increasing our shareholder value through increased revenue opportunities.” This newly established joint venture relationship will enable Trans Screen Group and Consorteum Holdings Inc. to expand into markets outside…

TuesdaySep 15, 2009 9:32 am

The Muscle Flex, Inc. (MFLI.PK) VATA Brasil(TM) Sports and Active Wear Collection to Be Included in Nominee Gift Basket

Muscle Flex Inc. announced this morning that its VATA Brasil(TM) Sports and Active Wear Collection will be included in the prestigious and exclusive "Everybody Wins at the Emmys Gift Basket" produced by Lash Fary and Distinctive Assets (www.DistinctiveAssets.com). Lash Fary founded Distinctive Assets which has provided the most coveted and sought after Gift Baskets to Hollywood celebrities and industry elite for more than ten years. Lash Fary is regarded as one of Hollywood's most influential product trend setters and high profile celebrity event organizers. Under his leadership, Distinctive Assets has set new standards for Gift Baskets and Gift Lounges for…

TuesdaySep 15, 2009 9:13 am

Consorteum Holdings, Inc.’s (CSRH.OB) Business Model Fits into Many Diverse Markets

Consorteum Holdings Inc., the innovative payment technology and applications company, has identified significant opportunities in the North American marketplace for all aspects of their business model. To this end, the company has worked on building solutions that are now portable into many diverse markets. For example, the solution set that the company has built for the payment of benefits lends itself to several areas in the North American marketplace. These areas include welfare payments and payments to all areas of government including the armed forces, government employees, and even the Native American population, such as Canada's First Nations community. The…

TuesdaySep 15, 2009 8:28 am

Longwei Petroleum (LPIH.OB) Reports Net Income and Revenue Guidance for Fiscal 2009

Longwei Petroleum Investment Holding Ltd. (LPIH.OB), one of the leading distributors and wholesalers of diesel, gasoline, kerosene and fuel oils in Taiyuan City in the People’s Republic of China, recently announced revenue of approximately $197 million for the fiscal year ended June 30, 2009. The company’s net income totaled $23.9 million, equating to earnings per share of $0.31. Longwei Petroleum also expects to raise capital of approximately $15 million in order to secure inventory and complete the construction of a 70,000-metric ton capacity storage tank facility in Gujiao City, which is expected to add approximately $40 million in revenue and…

TuesdaySep 15, 2009 8:27 am

Wykanta Acquires Asian Distribution Rights for Global Biotech Corp.’s (GBIQ.OB) Products

Global Biotech Corp., a publicly traded green consumer health products development company, recently announced that Wykanta International, Inc., an international nutraceuticals company, is acquiring the exclusive Asian distribution rights for all of Global Biotech’s product line. This agreement includes Global Biotech’s leading oxygenated product “Aquaboost™,” a water product well-positioned to become a leader in the fast-growing oxygenated water consumer market. Under the terms of the agreement, Wykanta International, Inc. will have the exclusive distribution rights for all Global Biotech’s new and existing products in the Asian market, including China, Japan, Korea, Thailand, Indonesia and India. The agreement applies to all…

TuesdaySep 15, 2009 8:25 am

Protalix Biotherapeutics, Inc. (PLX) Completes Phase III Trial for Gaucher Disease Treatment

Protalix Biotherapeutics, Inc. continues to make headlines with its innovative compound, a recombinant form of glucocerebrosidase (prGCD). Last week, the company released that its compound had received the FDA’s Orphan Drug Donation. Yesterday, the company announced that they have completed the Phase III trial for prGCD. The compound is designed to treat Gaucher disease, a rare and serious lysosomal storage disorder in humans with debilitating symptoms. Protalix plans to release top-line results from this study in October 2009, but has shed light on a few details; the trial enrolled 31 patients across Europe, North America, South America, Israel and South…

MondaySep 14, 2009 4:16 pm

September 14th CEOcast Weekly Newsletter

Companies featured in this edition of the newsletter: CUR, CVM, ENZ, IMUC, MBCI, ONEZ, PHC, SVUL Markets finished in positive territory yet again during this holiday shortened week despite the lack of any significant developments on either the corporate or economic fronts. All told, the Dow gained 164 points to close at 9605, up 1.7% on the week and 9.4% on the year. The Nasdaq gained 3.1% on the week, closing at 2080, up 32% on the year, while the S&P 500 and Russell 2000 gained 2.6% and 4.0% respectively on the week, up 15.4% and 18.8% on the year.…

MondaySep 14, 2009 2:45 pm

ALR Technologies, Inc. (ALRT) Up 425% Following QualityStocks Newsletter Mention

ALR Technologies, Inc.’s stock is currently trading at $0.21, up 425%, on massive volume of 3.3+ million traded shares. Earlier this month, QualityStocks highlighted the company in its daily newsletter when the stock was trading for only $0.04 and largely ignored by the investment community. To sign up for the newsletter, visit www.signup.qualitystocks.net. Today, ALR Technologies announced that the US Patent and Trademark Office has approved its patent application regarding patient compliance and remote monitoring of patient's use of nebulizer compressors. This approval protects the company’s Health-E-Connect health management communications system and, more importantly, grants ALRT the exclusive ability to…

Site Search

Company Search